Abridge
Unicorn Β· $5.3BPhiladelphia, US Β· Founded 2018 Β· Delaware corporation Β· 28 known investors
Abridge builds AI software that converts clinical conversations into structured insights for healthcare providers. The platform helps clinicians and patients by automating documentation and improving clinical decision-making from the conversation itself.
Also known as Abridge AI Β· Abridge AI Inc.
Founders & leadership
Abridge was founded in 2018 by Shiv Rao and Shiv (Shivdev) Rao.
Board
Investors Β· 28
Also in the syndicate Β· 1
Reported raises Β· per SEC filings
Form D private placements$458M disclosed across 3 of 5 rounds Β· 2018β2025
βΆ$315.9MraisedJun 2025 Β· 20 investors Β· Other TechnologyRule 506(b)
- Julia ChapinExecutive Officer
- Sagar SanghviExecutive Officer
- Andy WeissmanDirector
- Sebastian DuesterhoeftDirector
- Shivdev K. RaoExecutive Officer, Director
- Will ReedDirector
- Offering amount
- $319M
- Amount sold
- $315.9M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
βΆ$141.1MraisedMar 2024 Β· 15 investors Β· Other TechnologyRule 506(b)
- Andy WeissmanDirector
- Julia ChapinExecutive Officer
- Will ReedDirector
- Shivdev K. RaoExecutive Officer, Director
- Sebastian DuesterhoeftDirector
- Offering amount
- $150M
- Amount sold
- $141.1M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
βΆ$1MraisedApr 2018 Β· 1 investors Β· Other TechnologyRule 506(b)
- Shivdev K. RaoExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Amount sold
- $1M
- Proceeds to insiders
- $250K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation Β· disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed β follow each entry's link for the claim.
Company profile
researched Aug 2026Abridge develops an enterprise generative-AI platform for healthcare that captures clinician-patient conversations and converts them, in real time, into structured clinical note drafts that are integrated into the electronic health record. The company positions the product as a single "intelligence layer" spanning the care workflow: pre-visit preparation that surfaces patient history, prior visits and open care gaps; in-encounter ambient capture with clinical decision support, care-gap identification and order capture; and post-visit outputs including finalized notes, coding specificity, orders and patient summaries.
The platform is packaged into three tailored product experiences β for clinicians, for revenue cycle (billable documentation), and for nursing β together with capabilities branded Clinical Decision Support (CDS), Care Signals and a "Contextual Reasoning Engine." Clinical decision support draws on third-party evidence sources including UpToDate, the New England Journal of Medicine and JAMA. Abridge describes itself as serving health systems, payers and life sciences organizations, and states it is trusted by more than 300 health systems. CEO Shiv Rao has described Abridge as "in essence, a mid-revenue cycle company," because the notes it generates function as the basis for insurance billing.
A companion mobile application, "Abridge for Clinicians," is distributed on the Apple App Store by Abridge AI Inc. for iPhone and iPad; it records medical conversations without wake words or dictation and directs users to a web editor to review and finalize the draft note. A separate "Abridge for Patients" app is referenced.
Compiled by commissioned research from 8 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Founder mafia
4 people who came through Abridge went on to found or lead other companies.
Competitors Β· 3
by search overlapCompanies competing with Abridge for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline Β· 17
launches, deals, and filingsKLAS named Abridge market leader in the ambient AI segment for 2025 and 2026.
Reported by Becker's Healthcare as an exclusive; Kaiser Permanente is also described as launching its largest generative AI project in healthcare through Abridge.
Round led by a16z with participation from Khosla Ventures; proceeds earmarked for new products and embedding revenue cycle intelligence earlier in the clinical conversation.
$300M source β
Abridge extended its documentation tools from outpatient and emergency medicine to inpatient care, integrating into Epic workflows, and piloted a gen-AI outpatient orders feature through Epic's Workshop program.
Announced at ViVE 2025 alongside a new AI tool to streamline billable notes.
$250M source β
Following a pilot, Deaconess Health System expanded use of Abridge across its 19-hospital network.
Johns Hopkins Medicine deployed Abridge's ambient AI platform across 6,700 clinicians, six hospitals and 40 patient-care centers.
Abridge collaborated with Epic and Mayo Clinic on a generative AI ambient documentation workflow for nurses; Mayo Clinic expanded use of the platform enterprise-wide starting with about 2,000 clinicians.
Integration of UpToDate clinical evidence into Abridge's AI note-taking tool.
Abridge developed a medical record template for pediatric providers focused on primary care well visits and launched a generative AI product for emergency care.
Series C led by Lightspeed Venture Partners with co-lead Redpoint Ventures, four months after a $30M Series B; Lightspeed joined the board.
$150M source β
Yale New Haven Health selected Abridge as its generative AI partner for ambient listening, giving thousands of clinicians access to Abridge for clinical documentation.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities Β· 1
corporate structureIn the news
βΈResearch sources Β· 8
primary sources listed
- Abridgeabridge.com Β· web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Abridge do?
- Abridge builds generative AI that turns clinician-patient conversations into clinical documentation, coding and care insights.
- Who founded Abridge?
- Abridge was founded by Shiv Rao, Shiv (Shivdev) Rao in 2018.
- Who are Abridge's investors?
- Abridge's investors include Alpha Square Group, alphabet angels, Andreessen Horowitz, Bessemer Venture Partners, CapitalG, Catalio Capital Management, LP, Collective Liquidity, CVS Health Ventures and 19 more.
- How much funding has Abridge raised?
- Abridge has disclosed $458M raised across 3 of its 5 known rounds.
- Where is Abridge headquartered?
- Abridge is headquartered in Philadelphia, US.